首頁 > 市場調查報告書 > 醫療設備

麻醉

市場調查報告書

商品編碼

1606500

全球麻醉一次性用品市場 - 2024-2031

Global Anesthesia Disposables Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球麻醉一次性用品市場規模達11.2億美元，預計2031年將達到18.3億美元，2024-2031年預測期間複合年成長率為6.4%。

麻醉一次性用品是一類一次性醫療產品，主要用於在外科手術過程中使用麻醉劑。這些物品對於確保病人安全、防止交叉污染和維持手術室無菌環境至關重要。最常見的麻醉一次性用品是麻醉呼吸迴路、氣管插管、麻醉面罩和喉罩。這些組件中的每一個對於麻醉劑的成功輸送以及手術期間氣道管理和監測的促進至關重要。

慢性病盛行率的增加是預測期內推動市場的促進因素。例如，根據泛美衛生組織的數據，全球預計將有 2,000 萬人新診斷癌症，1,000 萬人因癌症死亡。未來二十年，癌症負擔將增加近 60%，給醫療保健系統、個人和社區帶來進一步的負擔。

市場動態：

驅動程式和限制

慢性病盛行率增加

癌症盛行率的增加預計將成為全球麻醉一次性用品市場成長的重要因素。慢性病日益普及預計將對全球麻醉一次性用品市場產生重大影響。糖尿病、高血壓、心血管疾病和呼吸系統疾病等慢性疾病經常需要進行外科手術，導致麻醉產品的需求增加。患有這些慢性疾病的患者在手術期間會遇到明顯的問題，因為他們的健康狀況會損害圍手術期。例如，患有糖尿病的人可能會出現傷口癒合延遲和更容易感染的情況，而患有心血管疾病的人在手術前後出現併發症的風險更高。這種複雜性需要專家的麻醉管理，這增加了對一次性麻醉設備的需求，以確保這些高風險患者的安全性和有效性。

例如，根據美國國立衛生研究院的數據，到 2023 年，美國預計將出現 1,958,310 例新癌症病例和 609,820 例癌症死亡病例。前列腺癌發生率在經歷了二十年的下降之後，從 2014 年到 2019 年每年上升 3%，導致新病例增加 99,000 例。年癌症發生率為每 10 萬名男性和女性 440.5 例（基於 2017 年至 2021 年的病例）。癌症死亡率（癌症死亡率）為每年每 10 萬名男性和女性 146.0 人（基於 2018 年至 2022 年的死亡人數）。到 2024 年，預計將有 14,910 名 0 至 19 歲的兒童和青少年被診斷出患有癌症，其中 1,590 人因此死亡。

此外，根據美國國立衛生研究院的數據，約有 4.62 億人患有第 2 型糖尿病，相當於世界人口的 6.28%。例如，根據美國疾病管制與預防中心的數據，大約有 3,840 萬各個年齡層的人（占美國人口的 11.6%）被診斷出患有糖尿病。在18歲及以上的成年人中，這一數字上升至3,810萬，占美國成年人總數的14.7%。

缺乏訓練有素的麻醉師

缺乏訓練有素的麻醉師等因素預計將阻礙全球麻醉一次性市場的發展。訓練有素的麻醉師和經過認證的註冊護理麻醉師 (CRNA) 的日益缺乏預計將對全球麻醉一次性用品行業產生重大影響。這種稀缺性是由多種變數引起的多維度問題，包括勞動力老化和手術需求不斷成長。由於醫療機構努力維持麻醉科適當的人員配備水平，提供及時有效的手術護理的能力受到影響，這對麻醉一次性消耗產生直接影響。

Anesthetic disposables are a category of single-use medical products created primarily for the administration of anesthetic during surgical procedures. These items are critical to guaranteeing patient safety, preventing cross-contamination, and maintaining a sterile environment in operating rooms. The most common forms of anesthetic disposables are anesthesia breathing circuits, endotracheal tubes, anesthesia masks, and laryngeal mask airways. Each of these components is critical to the successful delivery of anesthetic agents as well as the facilitation of airway management and monitoring during surgery.

The increasing prevalence of chronic diseases is the driving factor that drives the market over the forecast period. For instance, according to the Pan American Health Organization, globally, there were an expected 20 million new cancer diagnoses and 10 million cancer deaths. Over the next two decades, the cancer burden will rise by almost 60%, putting a further burden on healthcare systems, individuals, and communities.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The increasing prevalence of cancer is expected to be a significant factor in the growth of the global anesthesia disposables market. The increasing prevalence of chronic diseases is expected to have a substantial impact on the global anesthesia disposables market. Chronic ailments such as diabetes, hypertension, cardiovascular disease, and respiratory disorders frequently necessitate surgical procedures, resulting in increased demand for anesthetic products. Patients with these chronic disorders have distinct problems during surgery since their health can impair the perioperative procedure. Individuals with diabetes, for example, may experience delayed wound healing and greater susceptibility to infections, while those with cardiovascular disorders are at a higher risk of complications before and after surgery. This intricacy needs expert anesthetic management, which increases the demand for disposable anesthesia equipment that ensures safety and efficacy in these high-risk patients.

For instance, according to the National Institute of Health, in 2023, the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths. Prostate cancer incidence climbed by 3% every year from 2014 to 2019, after two decades of reduction, resulting in an additional 99,000 new cases. The annual cancer incidence rate is 440.5 per 100,000 men and women (based on cases from 2017 to 2021). The cancer death rate (cancer mortality) is 146.0 per 100,000 men and women annually (based on deaths from 2018-2022). In 2024, a projected 14,910 children and adolescents between the ages of 0 and 19 will be diagnosed with cancer, with 1,590 deaths from the condition.

Moreover, according to the National Institute of Health, approximately 462 million individuals were affected by type 2 diabetes corresponding to 6.28% of the world's population. For instance, according to the Centers for Disease Control and Prevention, approximately 38.4 million individuals of all ages, representing 11.6% of the U.S. population, were diagnosed with diabetes. Among adults aged 18 and older, this figure rose to 38.1 million, accounting for 14.7% of all U.S. adults.

Dearth of trained anaesthesiologists

Factors such as dearth of trained anaesthesiologists are expected to hamper the global anesthesia disposable market. The growing dearth of trained anesthesiologists and certified registered nurse anesthetists (CRNAs) is predicted to have a substantial impact on the worldwide anesthesia disposables industry. This scarcity is a multidimensional issue caused by a number of variables, including an aging workforce and a growing demand for surgery. As healthcare organizations struggle to maintain proper staffing levels in anesthesia departments, the capacity to offer timely and effective surgical care suffers, which has a direct impact on anesthesia disposable consumption.

Segment Analysis

The global anesthesia disposables market is segmented based on product, material, patient group, end user, and region.

Anaesthesia masks segment is expected to dominate the global anesthesia disposables market share

Anaesthesia masks segment is expected to dominate the global anesthesia disposables market share. The anesthesia masks segment is expected to dominate the worldwide anesthesia disposables market due to many compelling considerations that highlight its importance in surgical operations. Anesthesia masks, which are required for administering anesthetic gases and regulating patient breathing, are widely used in a variety of healthcare settings, including hospitals and ambulatory surgical centers. Their critical role in assuring patient safety and comfort during anesthetic administration makes them necessary in modern medical practice.

One of the key drivers of growth in the anesthesia masks industry is the growing number of surgical procedures conducted around the world and the increasing prevalence of chronic diseases. With advances in medical technology and an aging population necessitating surgical operations, the demand for effective anesthetic administration systems has increased. Anesthesia masks provide rapid and efficient ventilation, which is especially important in emergency situations and for patients undergoing short-term procedures. The shift to minimally invasive surgical techniques also contributes to this trend, as these operations frequently necessitate accurate and dependable anesthetic care, reinforcing the importance of anesthesia masks.

The increasing prevalence of chronic diseases results in an increase in the number of surgical procedures which increases the demand for anesthesia masks. For instance, according to the World Health Organization (WHO), cancer diagnoses are predicted to exceed 22 million by 2023 and in the case of breast cancer, 1 in 12 women will be diagnosed with breast cancer in their lifetime and 1 in 71 women die of it.

Geographical Analysis

North America is expected to hold a significant position in the global anesthesia disposables market share

North America is expected to maintain its dominant position in the global anesthetic disposables market due to several key factors. One significant driver is the region's high prevalence of chronic diseases, which results in an increasing number of surgical procedures. Conditions such as cardiovascular diseases, cancer, diabetes, and respiratory disorders are common, leading to a higher volume of procedures that require effective anesthetic management. Consequently, the demand for disposable anesthetic devices-including masks, tubes, and breathing circuits-continues to rise.

For example, according to the National Institutes of Health, the United States is projected to see 2,001,140 new cancer cases and 611,720 cancer-related deaths in 2024. While cancer mortality has decreased overall due to reductions in smoking, earlier detection, and improved treatments, this progress is being overshadowed by a rising incidence of six of the top ten cancers. This growing demand for surgical interventions and anesthetic management will further fuel the need for anesthetic disposables in the region.

Asia Pacific is growing at the fastest pace in the global anesthesia disposables market

Asia Pacific is experiencing the fastest growth in global anesthesia disposables owing to the increasing incidence of chronic diseases in the region. Asia Pacific experiences the greatest growth in the worldwide anesthetic disposables market, owing to a combination of variables that improve surgical capabilities and healthcare access throughout the region. One of the key drivers of this expansion is the increased volume of surgical procedures, which is mostly due to the rising prevalence of chronic conditions. As populations in nations like as China and India age and urbanize, there is an increase in health problems that necessitate surgical procedures. This trend calls for a higher dependence on anesthesia disposables as healthcare providers strive to assure patient safety and reduce infection risks during surgeries. For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively.

Competitive Landscape

The major global players in the global anesthesia disposables market include Ambu A/S, Dragerwerk AG & Co. KGaA, Teleflex Incorporated, Hamilton Medical, Intersurgical Ltd, Medline Industries, LP, Medtronic, Mercury Medical, Sharn Anesthesia, Narang Medical Limited among others.

Emerging Players

Conus Airway, Solvet among others

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global anesthesia disposables market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Material
3.3. Snippet by Patient Group
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. Dearth Of Trained Anaesthesiologists
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. Laryngoscope*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Resuscitators
6.4. Anaesthesia Masks
6.5. Breathing Bags
6.6. Breathing Circuits
6.7. Endotracheal Tubes
6.8. Intubation Accessories
6.9. Laryngeal Mask Airways

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Plastic*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Silicone

8. By Patient Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 8.1.2. Market Attractiveness Index, By Patient Group
8.2. Neonatal*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adult
8.4. Paediatric

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Home Care Settings
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Ambu A/S*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Dragerwerk AG & Co. KGaA
12.3. Teleflex Incorporated
12.4. Hamilton Medical
12.5. Intersurgical Ltd
12.6. Medline Industries, LP
12.7. Medtronic
12.8. Mercury Medical
12.9. Sharn Anesthesia
12.10. Narang Medical Limited

LIST NOT EXHAUSTIVE